Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 13 (12), 1535-47

Animal Modeling of Cancer Pathology and Studying Tumor Response to Therapy

Affiliations
Review

Animal Modeling of Cancer Pathology and Studying Tumor Response to Therapy

Simon P Langdon. Curr Drug Targets.

Abstract

Animal models of human cancer have evolved in attempts to capture the complexity of the human disease. They encompass two broad types of model, namely those in which the tumor arises in situ and those in which cancer cells or tissue are transplanted. Currently human tumor xenografts are the most widely used model to help predict antitumor efficacy in a preclinical setting and xenograft results for certain disease types such as ovarian cancer and non-small cell lung cancer correlate well with clinical activity if the models are used under appropriate conditions. The genetically engineered mouse (GEM) models allow study of the effects of targeted inhibitors against defined molecular targets. These are becoming increasingly sophisticated to recapitulate the progression of tissue-specific molecular changes found within individual cancers. Non-germline GEM models possess the ability to study the impact of specific cancer genes without some of the limitations inherent in traditional GEM models. While rodents, particularly mice, have been the animal host most frequently used, there is increasing recognition of the value of using larger species especially dogs in the veterinary oncology setting. These have successfully modelled aspects of selected human cancers such as osteosarcoma, GIST and prostate cancer. Individually, these models have relative strengths and weaknesses in mimicking the human disease and appropriately reflecting its cellular and molecular pathology. This review will seek to address where these models can be best used to help predict response to therapeutics.

Similar articles

  • In Vivo Pharmacology Models for Cancer Target Research
    D Chen et al. Methods Mol Biol 1953, 183-211. PMID 30912023.
    Experimental animal tumor models have been broadly used to evaluate anticancer drugs in the preclinical setting. They have also been widely applied for drug target discov …
  • Mouse Tumour Models to Guide Drug Development and Identify Resistance Mechanisms
    M Das Thakur et al. J Pathol 232 (2), 103-11. PMID 24122209. - Review
    We need improved, translatable and predictive tumour models for the evaluation of response and the evolution of resistance to targeted therapeutics. We provide a review o …
  • Mouse Models in Oncogenesis and Cancer Therapy
    MV Céspedes et al. Clin Transl Oncol 8 (5), 318-29. PMID 16760006. - Review
    Animal models have been critical in the study of the molecular mechanisms of cancer and in the development of new antitumor agents; nevertheless, there is still much room …
  • Drug Discovery in Prostate Cancer Mouse Models
    KC Valkenburg et al. Expert Opin Drug Discov 10 (9), 1011-24. PMID 26027638. - Review
    With proper planning and following practical guidelines by the researcher, the mouse is a powerful experimental tool. The field lacks genetically engineered metastatic mo …
  • Mouse Models of Colorectal Cancer as Preclinical Models
    RE McIntyre et al. Bioessays 37 (8), 909-20. PMID 26115037. - Review
    In this review, we discuss the application of mouse models to the identification and pre-clinical validation of novel therapeutic targets in colorectal cancer, and to the …
See all similar articles

Cited by 15 PubMed Central articles

See all "Cited by" articles

MeSH terms

Substances

Feedback